One useful anti-cancer drug can effectively erase the whorls and other characteristic marks that give people their distinctive fingerprints. Losing (1) could become troublesome. A case released online in a letter by Annals of Oncology indicates how big a (2) of losing fingerprints is. Eng-Huat Tan, a Singapore-based medical doctor describes a 62-year old man who has used capecitabine to (3) his nasopharyngeal cancer. After three years on the (4) . the patient decided to visit U. S. relatives last December. But he was stopped by U. S. customs officials (5) 4 hours after entering the country when those officials couldn't get fingerpints from the man. There were no distinctive swirly (6) appearing from his index finger. U. S. customs has been fingerprinting incoming foreign visitors for years, Tan says. Their index fingers are (7) and screened against digital files of the fingerprints of bad guys-terrorists and potential criminals that our federal guardians have been tasked with keeping out of the country. Unfortunately, for the Singaporean traveler, one potential (8) effect of his drug treatment is a smoothing of the tissue on the finger pads. (9) , no fingerprints. "It is uncertain when fingerprint loss will (10) to take place in patients who are taking capecitabine, " Tan points out. So he cautions any physicians who (11) the drug to provide their patients with a doctor's note pointing out that their medicine may cause fingerprints to disappear. Eventually, the Singapore traveler made it into the United States. I guess the name on his passport didn't raise any red flags. But he's also now got the explanatory doctor's note — and won't leave home (12) it. By the way, maybe the Food and Drug Administration, (13) approved use of the drug 11 years ago, should consider (14) its list of side effects associated with this medicine. The current list does note that patients may experience vomiting, stomach pain and some other side effects. But no where (15) it mention the potential for loss of fingerprints.
【答案解析】[解析] 哪一个政府机构许可( approved)使用该类抗癌药?就是本段第一句提到的the Food and Drug Administration。四个选项中,只有关系代词which能指代the Food and Drug Administration,它是approved动作的发出者。
单选题
A. updating B. using C. printing D. cancelling
【答案解析】[解析] 最后一段最后一句中,为了强调no where,将它移到句首,这时,原句的“it does not mention the potential for loss of fingerprints”就要写成强调句形式的“no where does it mention the potential for loss of fingerprints”。所以,答案是B。